GenFleet Therapeutics
Shanghai · Founded 2017
About GenFleet Therapeutics
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $169.4M
- Funding stage: IPO
- Last round: Series C (Dec 2021)
- Ticker: hkg:2595
- Website: http://www.genfleet.com/en
- Phone: 021-6882 1388
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/genfleet-therapeutics-126776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.